- Home
- CPAC vs SIGA Comparison
CPAC vs SIGA Comparison
Compare CPAC & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- SIGA
- Stock Information
- Founded
- CPAC 1949
- SIGA 1995
- Country
- CPAC Peru
- SIGA United States
- Employees
- CPAC N/A
- SIGA N/A
- Industry
- CPAC Building Materials
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- SIGA Health Care
- Exchange
- CPAC Nasdaq
- SIGA Nasdaq
- Market Cap
- CPAC 475.3M
- SIGA 443.4M
- IPO Year
- CPAC 2012
- SIGA 1997
- Fundamental
- Price
- CPAC $5.77
- SIGA $5.91
- Analyst Decision
- CPAC Sell
- SIGA
- Analyst Count
- CPAC 1
- SIGA 0
- Target Price
- CPAC $6.00
- SIGA N/A
- AVG Volume (30 Days)
- CPAC 5.1K
- SIGA 401.8K
- Earning Date
- CPAC 03-04-2025
- SIGA 03-11-2025
- Dividend Yield
- CPAC 8.69%
- SIGA 10.16%
- EPS Growth
- CPAC 17.75
- SIGA N/A
- EPS
- CPAC 0.12
- SIGA 1.20
- Revenue
- CPAC $524,464,683.00
- SIGA $173,731,386.00
- Revenue This Year
- CPAC N/A
- SIGA $16.79
- Revenue Next Year
- CPAC N/A
- SIGA $15.08
- P/E Ratio
- CPAC $9.19
- SIGA $4.94
- Revenue Growth
- CPAC 1.44
- SIGA 399.31
- 52 Week Low
- CPAC $5.10
- SIGA $4.75
- 52 Week High
- CPAC $6.65
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- CPAC 49.77
- SIGA 43.23
- Support Level
- CPAC $5.70
- SIGA $5.80
- Resistance Level
- CPAC $6.00
- SIGA $6.25
- Average True Range (ATR)
- CPAC 0.15
- SIGA 0.23
- MACD
- CPAC -0.01
- SIGA 0.01
- Stochastic Oscillator
- CPAC 31.88
- SIGA 43.44
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.